Identification | Back Directory | [Name]
4-(4-BROMOPHENYL)BUTANOIC ACID | [CAS]
35656-89-4 | [Synonyms]
4-broMo-Benzenebutanoic acid 4-(4-Bromophenyl)butanic acid 4-(4-BROMOPHENYL)BUTYRIC ACID 4-(4-BROMOPHENYL)BUTANOIC ACID | [Molecular Formula]
C10H11BrO2 | [MDL Number]
MFCD00463170 | [MOL File]
35656-89-4.mol | [Molecular Weight]
243.1 |
Chemical Properties | Back Directory | [Melting point ]
67 °C | [Boiling point ]
176 °C / 3mmHg | [density ]
1.463±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
soluble in Methanol | [form ]
powder to crystal | [pka]
4.74±0.10(Predicted) | [color ]
White to Light yellow to Light orange | [InChIKey]
AGIIMNQWNPUJPT-UHFFFAOYSA-N | [CAS DataBase Reference]
35656-89-4 |
Hazard Information | Back Directory | [Synthesis]
General procedure for the synthesis of 4-(4-bromophenyl)butyric acid from 3-(4-bromobenzoyl)propionic acid: zinc powder (13.0 g, 200 mmol) was stirred with mercuric chloride (1.00 g, 4.80 mmol) in water (10 mL) and concentrated hydrochloric acid (0.6 mL) for 5 min. After decanting the liquid, toluene (20 mL), concentrated hydrochloric acid (20 mL) and water (8 mL) were added sequentially. 3-(4-Bromobenzoyl)propionic acid (2.55 g, 10.5 mmol) was added to the reaction system and heated at reflux at 100 °C for 24 h, during which concentrated hydrochloric acid (1 mL) was replenished every 6 hours. After completion of the reaction, it was cooled to room temperature, filtered, and the solvent was removed from the organic phase to give a clarified liquid, which precipitated as white crystals upon cooling. The product was purified by silica gel column chromatography (eluent: ethyl acetate/hexane, 1:3, v/v) to afford 4-(4-bromophenyl)butanoic acid (2.33 g, 9.63 mmol, 91.4% yield). Mass spectrometry (ESI-quadrupole) m/z: calculated values of C10H11BrO2[M-H]-: 241.99, 243.99; measured values: 244.0 (10%), 243.0 (98%), 242.0 (11%), 241.0 (100%) (negative ion mode). High performance liquid chromatography (HPLC) retention time: 27.7 min. 1H NMR (300 MHz, CDCl3) δ (ppm): 7.40 (2H, d, J = 8.4 Hz, ArH), 7.06 (2H, d, J = 8.4 Hz, ArH), 2.63 (2H, t, J = 7.8 Hz, CH2), 2.36 (2H, t, J = 7.2 Hz, CH2), 1.97 (2H, dt, J = 7.2, 7.8 Hz, CH2), OH was not observed. | [References]
[1] Journal of the American Chemical Society, 2001, vol. 123, # 17, p. 3940 - 3952 [2] Journal of Organic Chemistry, 1992, vol. 57, # 1, p. 366 - 370 [3] Patent: WO2016/119017, 2016, A1. Location in patent: Page/Page column 22; 31 [4] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 22, p. 7434 - 7445 [5] Patent: WO2015/134973, 2015, A1. Location in patent: Page/Page column 123; 124 |
|
|